(相關(guān)資料圖)
CFi.CN訊：瑞康醫(yī)藥（股票代碼：002589）公布2025年半年度報(bào)告摘要。
本報(bào)告期上年同期本報(bào)告期比上年同期增減調(diào)整前調(diào)整后調(diào)整后營(yíng)業(yè)收入（元）3,543,520,195.094,031,665,203.804,031,665,203.80-12.11%歸屬于上市公司股東的凈利潤(rùn)（元）18,166,445.2831,025,324.7426,852,518.23-32.35%歸屬于上市公司股東的扣除非經(jīng)常性損益的凈利潤(rùn)（元）2,899,545.506,207,108.972,034,130.0242.54%經(jīng)營(yíng)活動(dòng)產(chǎn)生的現(xiàn)金流量?jī)纛~（元）67,886,098.549,333,575.169,146,646.10642.20%基本每股收益（元/股）0.01210.02060.0178-32.02%稀釋每股收益（元/股）0.01210.02060.0178-32.02%加權(quán)平均凈資產(chǎn)收益率0.33%0.57%0.49%-0.16%本報(bào)告期末上年度末本報(bào)告期末比上年度末增減調(diào)整前調(diào)整后調(diào)整后總資產(chǎn)（元）17,288,636,016.5416,012,320,005.0216,037,471,948.367.80%歸屬于上市公司股東的凈資產(chǎn)（元）5,355,003,490.145,537,791,736.875,548,487,656.81-3.49%
